Interestingly, the sensitivities of methylated TFAP2B and TAC1 for RCC SRMs were even higher than that of needle biopsy, which possibly is the result of RCC heterogeneity that is highly overlooked in single biopsy studies [27,28,29]. This evidence concerns the gene TAC1 and renal cell carcinoma.